Health plan cost trends continue to put major financial pressure on group health plan sponsors. On October 9, Segal experts will outline the key findings from the 2025 Segal Health Plan Cost Trend Survey, including the double-digit projected trend for outpatient prescription drugs and the top strategies plan sponsors are using this year to manage health plan costs, most of which focus on Rx coverage.
They’ll also examine some of the key issues that group health plan sponsors should consider when developing a custom cost-management strategy that maintains high-quality standards and access to healthcare services.
Our survey of health insurers, managed care organizations, PBMs and TPAs represents more than 80 percent of the commercially insured and self-insured market. Join us to learn what they told us about their 2025 trend projections.
Jason Jossie, ASA, MAAA
Vice President and Consulting Actuary
Eric Miller, FSA, CERA, MAAA
Vice President and Consulting Actuary
Matthew Nguyen, PharmD, BCPS
Vice President and Consultant Healthcare Informatics
Health, Higher Education, Healthcare Industry, Public Sector, Multiemployer Plans, Architecture Engineering & Construction, Pharmaceutical, Corporate
Health, Public Sector
Health, Benefits Administration, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate
This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.
© 2024 by The Segal Group, Inc.Terms & Conditions Privacy Policy California Residents Sitemap Disclosure of Compensation Required Notices
We use cookies to collect information about how you use segalco.com.
We use this information to make the website work as well as possible and improve our offering to you.